Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Clinical trial NCT05728268 · RECRUITING
Trial details
- NCT number
- NCT05728268
- Sponsor
- Shantou Central Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2024-12-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.